Cargando…

Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma

BACKGROUND: Anaplastic lymphoma kinase (ALK) is a key oncogenic driver in lung adenocarcinoma patients and its fusion proteins are routinely assessed. The microfluidic tissue processor (MTP) device is based on a chip-confined low-volume technology allowing for rapid immunohistochemistry/immunofluore...

Descripción completa

Detalles Bibliográficos
Autores principales: Brajkovic, Saška, Pelz, Benjamin, Procopio, Maria-Giuseppina, Leblond, Anne-Laure, Repond, Grégoire, Schaub-Clerigué, Ariane, Dupouy, Diego G, Soltermann, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192181/
https://www.ncbi.nlm.nih.gov/pubmed/30326973
http://dx.doi.org/10.1186/s13000-018-0757-1
_version_ 1783363860192821248
author Brajkovic, Saška
Pelz, Benjamin
Procopio, Maria-Giuseppina
Leblond, Anne-Laure
Repond, Grégoire
Schaub-Clerigué, Ariane
Dupouy, Diego G
Soltermann, Alex
author_facet Brajkovic, Saška
Pelz, Benjamin
Procopio, Maria-Giuseppina
Leblond, Anne-Laure
Repond, Grégoire
Schaub-Clerigué, Ariane
Dupouy, Diego G
Soltermann, Alex
author_sort Brajkovic, Saška
collection PubMed
description BACKGROUND: Anaplastic lymphoma kinase (ALK) is a key oncogenic driver in lung adenocarcinoma patients and its fusion proteins are routinely assessed. The microfluidic tissue processor (MTP) device is based on a chip-confined low-volume technology allowing for rapid immunohistochemistry/immunofluorescence (IHC/IF) stainings of formalin-fixed paraffin-embedded (FFPE) or frozen tissue samples. METHODS: A novel ALK IF protocol was developed for the MTP device using the primary mouse anti-human ALK antibody clone 5A4. FFPE tumor whole sections from 14 resected lung adenocarcinoma patients documented to be ALK positive (ALK+) by automated chromogenic IHC and/or FISH were used. MTP-derived IF immunoreactivity was measured by computerized analysis of digitalized images on individual frames of tumor epithelia and surrounding stroma, using an ImageJ plug-in. RESULTS: The 5A4 antibody yielded saturated immunoreactivity at an incubation time of 4 min on a titration curve ranging from 2 to 32 min. Total staining time on the MTP device was 18 min including secondary IgG Alexa Fluor 647. MTP-based ALK IF confirmed all 12 cases; with epithelial signal above stromal staining based on computerized pixel-based measurement. MTP-IF (mean intensity levels 458 to 1301) and chromogenic IHC (H-score 120 to 300) showed an equal range of variation of 2.8 and 2.5 folds, respectively, and a trend for direct correlation (p-value 0.051). CONCLUSION: The newly developed protocol for immunofluorescent detection of ALK protein with the MTP device confirms chromogenic IHC results on FFPE lung adenocarcinoma specimens. MTP-based IF is fast and reliable. We foresee this study to be a first step opening the road for further realization of microfluidic-based assays for rapid simultaneous detection of targetable oncogenic and immune-system related markers in their topographical context to investigate tumour heterogeneity and micro-environmental interactions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13000-018-0757-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6192181
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61921812018-10-22 Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma Brajkovic, Saška Pelz, Benjamin Procopio, Maria-Giuseppina Leblond, Anne-Laure Repond, Grégoire Schaub-Clerigué, Ariane Dupouy, Diego G Soltermann, Alex Diagn Pathol Research BACKGROUND: Anaplastic lymphoma kinase (ALK) is a key oncogenic driver in lung adenocarcinoma patients and its fusion proteins are routinely assessed. The microfluidic tissue processor (MTP) device is based on a chip-confined low-volume technology allowing for rapid immunohistochemistry/immunofluorescence (IHC/IF) stainings of formalin-fixed paraffin-embedded (FFPE) or frozen tissue samples. METHODS: A novel ALK IF protocol was developed for the MTP device using the primary mouse anti-human ALK antibody clone 5A4. FFPE tumor whole sections from 14 resected lung adenocarcinoma patients documented to be ALK positive (ALK+) by automated chromogenic IHC and/or FISH were used. MTP-derived IF immunoreactivity was measured by computerized analysis of digitalized images on individual frames of tumor epithelia and surrounding stroma, using an ImageJ plug-in. RESULTS: The 5A4 antibody yielded saturated immunoreactivity at an incubation time of 4 min on a titration curve ranging from 2 to 32 min. Total staining time on the MTP device was 18 min including secondary IgG Alexa Fluor 647. MTP-based ALK IF confirmed all 12 cases; with epithelial signal above stromal staining based on computerized pixel-based measurement. MTP-IF (mean intensity levels 458 to 1301) and chromogenic IHC (H-score 120 to 300) showed an equal range of variation of 2.8 and 2.5 folds, respectively, and a trend for direct correlation (p-value 0.051). CONCLUSION: The newly developed protocol for immunofluorescent detection of ALK protein with the MTP device confirms chromogenic IHC results on FFPE lung adenocarcinoma specimens. MTP-based IF is fast and reliable. We foresee this study to be a first step opening the road for further realization of microfluidic-based assays for rapid simultaneous detection of targetable oncogenic and immune-system related markers in their topographical context to investigate tumour heterogeneity and micro-environmental interactions. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13000-018-0757-1) contains supplementary material, which is available to authorized users. BioMed Central 2018-10-16 /pmc/articles/PMC6192181/ /pubmed/30326973 http://dx.doi.org/10.1186/s13000-018-0757-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Brajkovic, Saška
Pelz, Benjamin
Procopio, Maria-Giuseppina
Leblond, Anne-Laure
Repond, Grégoire
Schaub-Clerigué, Ariane
Dupouy, Diego G
Soltermann, Alex
Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title_full Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title_fullStr Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title_full_unstemmed Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title_short Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma
title_sort microfluidics-based immunofluorescence for fast staining of alk in lung adenocarcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192181/
https://www.ncbi.nlm.nih.gov/pubmed/30326973
http://dx.doi.org/10.1186/s13000-018-0757-1
work_keys_str_mv AT brajkovicsaska microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT pelzbenjamin microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT procopiomariagiuseppina microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT leblondannelaure microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT repondgregoire microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT schaubclerigueariane microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT dupouydiegog microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma
AT soltermannalex microfluidicsbasedimmunofluorescenceforfaststainingofalkinlungadenocarcinoma